Clinical and psychosexual characterization of patients with female orgasmic disorder

Authors

DOI:

https://doi.org/10.59471/ijhsc2025237

Keywords:

sexual dysfunctions, female sexual dysfunction, female orgasmic disorder

Abstract

Introduction: female orgasmic disorder (FOD) is a health problem that affects the physical and mental well-being of women, as well as their family, social and work balance. It has a high prevalence and incidence, and has organic and non-organic causes. 
Aim: to characterize patients with FOD assessed in a specialized consultation over a 15-month period. 
Methods: a descriptive, observational, cross-sectional study was conducted. Theoretical, empirical and statistical-mathematical methods were used. In the sexual counseling and therapy consultation for sexual ailments at the National Center for Sexology (CENESEX) in Cuba, 39 patients diagnosed with FOD, ranging from 16 to 45 years, were characterized. Their clinical histories were reviewed and a questionnaire written by CENESEX specialists was used as a data collection procedure. 
Results: in the evaluated patients with TOF, deficiencies related to sexual illiteracy were identified, particularly in relation to the organs of sexual response and the human sexual response cycle, attachment to mysticism and false beliefs, lack of knowledge of risk factors associated with TOF and inappropriate lifestyles. 

References

Sexual health, human rights and the law. Geneva, World Health Organization. 2015. http://www.who.int/reproductivehealth/publications/sexual_health/sexualhealth-human-rights-law/en/

RMR Cancio. Estudio epidemiológico de la disfunción sexual femenina: asociación con otras enfermedades y factores de riesgo (Tesis doctorado). 2010. Ministerio de Salud Pública, Universidad de Ciencias Médicas de La Habana. http://tesis.sld.cu/index.php/index.php?P=DownloadFile&Id=656

Ford JV, Corona-Vargas E, Cruz M, Fortenberry JD, Kismodi E, Philpott A, Coleman E. The World Association for Sexual Health’s declaration on sexual pleasure: A technical guide. International Journal of Sexual Health. 2021; 33(4):612-642. https://doi.org/10.1080/19317611.2021.2023718

Camacho-yLópez SM, Chávez-Martínez LC, Martínez-Campos JF, Padrón-Arce A, Rivera-Suárez EE, Tapia-Rodríguez RA Sexología basada en evidencia: la respuesta sexual humana y sus disfunciones. XIKUA Boletín Científico de la Escuela Superior de Tlahuelilpan. 2022; 10(20):18-26. https://doi.org/10.29057/xikua.v10i20.9109

International Statistical Classification of Diseases and Related Health Problems (11th (ICD-11) ed.). Geneva, Switzerland: World Health Organization (WHO). 2022. https://www.who.int/standards/classifications/classification-of-diseases

Davis SR. Sexual Dysfunction in Women. N Engl J Med. 2024; 391(8):736-745. https://www.nejm.org/doi/full/10.1056/NEJMcp2313307

Parish SJ, Hahn SR, Goldstein SW, Giraldi, A, Kingsberg SA, Larkin L, et al. The International Society for the Study of Women’s Sexual Health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc. 2019; 94:842-856. https://www.sciencedirect.com/science/article/pii/S0025619619300643

Romero Hung M, Aguilar Amaya R, Viera Bravo A. Caracterización de las disfunciones sexuales en el policlínico Vedado. Octubre 2013 a Enero 2015. En: Memorias del 7mo. Congreso de Educación, Orientación y Terapia Sexual. La Habana, Cuba, septiembre de 2015 (ISBN: 978-959-7187-74-5).

Frühauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013; 42:915-933. https://doi.org/10.1007/s10508-012-0062-0

Salari N, Hasheminezhad R, Almasi A, Hemmati M, Shohaimi S, Akbari H, Mohammadi Ml. The risk of sexual dysfunction associated with alcohol consumption in women: a systematic review and meta-analysis. BMC Women's Health. 2023; 23:213. https://doi.org/10.1186/s12905-023-02400-5

Lunelli RP, Irigoyen MC, Goldmeier S. Hypertension as a risk factor for female sexual dysfunction: cross-sectional study. Rev Bras Enferm [Internet]. 2018 [citado 24 mar 2025]; 71(5):2477-2482. https://doi.org/10.1590/0034-7167-2017-0259

Meza Dávalos MB, Morales Trejo EB. Orgasmo Femenino. Una Mirada Multidisciplinar. 2022. Disponible en: http://dspace.uan.mx:8080/handle/123456789/2503

Zamponi V, Mazzilli R, Bitterman O, Olana S, Iorio C, Festa C, Giuliani C, Mazzilli F, Napoli A. Association between type 1 diabetes and female sexual dysfunction. BMC Womens Health. 2018; 16;20(1):73. https://doi.org/10.1186/s12905-020-00939-1

Carosa E, Sansone A, Jannini EA. Management of endocrine disease: Female sexual dysfunction for the endocrinologist, Eur J Endocrinol. 2020; 182(6):R101. https://doi.org/10.1530/EJE-19-0903

Salari N, Moradi M, Hosseinian-Far A, Khodayari y, Masoud M. Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis. J Diabetes Metab Disord. 2023; 22:1011-1019. https://doi.org/10.1007/s40200-023-01267-5.

Downloads

Published

2025-04-07

Issue

Section

Original

How to Cite

1.
Mey-King Romero Hung M-K, Aguilar Amaya RJ, Rodríguez Martínez AD, Serrano Ramírez M, Soto Plutín Y, Garzón Cutiño L, et al. Clinical and psychosexual characterization of patients with female orgasmic disorder. Interamerican Journal of Health Sciences [Internet]. 2025 Apr. 7 [cited 2025 Apr. 23];5:237. Available from: https://ijhsc.uai.edu.ar/index.php/ijhsc/article/view/237